ADELPHI, Maryland (Reuters) - Drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch should be simplified to better explain the risk of blood clots. Advisers to the Food and Drug Administration, in a sweeping 20 to three vote with one abstention on Friday, found the current label for Ortho Evra, the only contraceptive patch sold in the country, inadequately reflects the risks women face by using it. ... Original Source
No comments:
Post a Comment